Compounds > 6-(n-(4-aminobutyl)-n-ethyl)amino-2,3-dihydrophthalazine-1,4-dione
Page last updated: 2024-09-05

6-(n-(4-aminobutyl)-n-ethyl)amino-2,3-dihydrophthalazine-1,4-dione and natriuretic peptide, brain

6-(n-(4-aminobutyl)-n-ethyl)amino-2,3-dihydrophthalazine-1,4-dione has been researched along with natriuretic peptide, brain in 1 studies

Compound Research Comparison

Studies
(6-(n-(4-aminobutyl)-n-ethyl)amino-2,3-dihydrophthalazine-1,4-dione)		Trials
(6-(n-(4-aminobutyl)-n-ethyl)amino-2,3-dihydrophthalazine-1,4-dione)		Recent Studies (post-2010)
(6-(n-(4-aminobutyl)-n-ethyl)amino-2,3-dihydrophthalazine-1,4-dione)		Studies
(natriuretic peptide, brain)		Trials
(natriuretic peptide, brain)		Recent Studies (post-2010) (natriuretic peptide, brain)
4902816,3171,8678,887

Protein Interaction Comparison

ProteinTaxonomy6-(n-(4-aminobutyl)-n-ethyl)amino-2,3-dihydrophthalazine-1,4-dione (IC50)natriuretic peptide, brain (IC50)
Atrial natriuretic peptide receptor 1Homo sapiens (human)0.006

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Adamantidou, C; Ahn, S; Gruson, D; Rousseau, M1

Other Studies

1 other study(ies) available for 6-(n-(4-aminobutyl)-n-ethyl)amino-2,3-dihydrophthalazine-1,4-dione and natriuretic peptide, brain

ArticleYear
Performances of a novel chemiluninescence ABEI-based NT-proBNP immunoassay.
    Acta cardiologica, 2022, Volume: 77, Issue:2

    Topics: Biomarkers; Heart Failure; Humans; Immunoassay; Luminol; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis

2022